Related Experiment Video

Updated: Aug 30, 2026

A Detailed Protocol for Characterizing the Murine C1498 Cell Line and its Associated Leukemia Mouse Model
08:00

A Detailed Protocol for Characterizing the Murine C1498 Cell Line and its Associated Leukemia Mouse Model

Published on: October 14, 2016

Juvenile myelomonocytic leukemia

Charlotte Marie Niemeyer1, Christian Kratz

  • 1Division of Pediatric Hematology and Oncology, Department of Pediatrics and Adolescent Medicine, University of Freiburg, Mathildenstrasse 1, 79106 Freiburg, Germany. Niemeyer@kikli.ukl.uni-freiburg.de

Current Oncology Reports
|October 3, 2003
PubMed

Insights

Juvenile myelomonocytic leukemia (JMML) is a childhood cancer curable by stem cell transplantation (SCT). Managing immunosuppression and exploring novel therapies targeting Ras/MAPK pathways are key for improving SCT outcomes in children with JMML.

Area of Science:

  • Pediatric Oncology
  • Hematology
  • Immunology

Background:

  • Juvenile myelomonocytic leukemia (JMML) is an aggressive childhood neoplasia.
  • Allogeneic stem cell transplantation (SCT) is the only curative option for JMML.
  • High relapse rates post-SCT necessitate optimized treatment strategies.

Purpose of the Study:

  • To review the current treatment landscape for JMML, focusing on SCT.
  • To evaluate the role of pretransplant cytoreductive treatments.
  • To explore novel therapeutic targets in JMML pathophysiology.

Main Methods:

  • Literature review of SCT outcomes in pediatric JMML.
  • Analysis of pretransplant interventions and their impact on relapse rates.
  • Examination of the role of granulocyte-macrophage colony-stimulating factor hypersensitivity and Ras/MAPK pathway activation.

Main Results:

  • Allogeneic SCT is the standard of care for JMML, with unrelated donor SCT being crucial when family donors are unavailable.
  • The impact of pretransplant cytoreductive therapies (chemotherapy, splenectomy, 13-cis retinoic acid) on SCT outcomes remains unclear.
  • Ras/MAPK pathway activation and GM-CSF hypersensitivity are critical in JMML pathogenesis.

Conclusions:

  • Optimizing immunosuppression management is vital for successful SCT in JMML.
  • Further research is needed to clarify the role of pretransplant treatments.
  • Targeting the Ras/MAPK pathway offers promising avenues for novel JMML therapies.

More Related Videos

Identifying Bone Marrow Microenvironmental Populations in Myelodysplastic Syndrome and Acute Myeloid Leukemia06:33

Identifying Bone Marrow Microenvironmental Populations in Myelodysplastic Syndrome and Acute Myeloid Leukemia

Published on: November 10, 2023

Comprehensive Protocol to Sample and Process Bone Marrow for Measuring Measurable Residual Disease and Leukemic Stem Cells in Acute Myeloid Leukemia09:57

Comprehensive Protocol to Sample and Process Bone Marrow for Measuring Measurable Residual Disease and Leukemic Stem Cells in Acute Myeloid Leukemia

Published on: March 5, 2018

Related Concept Videos

Differentiation of Common Myeloid Progenitor Cells01:15

Differentiation of Common Myeloid Progenitor Cells

Common myeloid progenitors (CMPs) are oligopotent cells that can differentiate into granulocytes and macrophages. Granulocytes and macrophages are essential for protecting the body against bacterial, viral, or fungal infections. They migrate from the bone marrow into the circulating blood to reach specific tissue sites where they differentiate and help in immune surveillance. However, they survive only for a few days and must be continuously made available to the organism to maintain a robust...
Disorders of Leukocytes01:27

Disorders of Leukocytes

Leukocyte disorders can lead to either leukopenia, characterized by an abnormally low leukocyte count, or leukocytosis, marked by a very high leukocyte number.
Leukopenia may result from bone marrow disorders, autoimmune diseases, and infectious diseases. For example, conditions such as multiple myeloma and aplastic anemia can impair the bone marrow's ability to produce adequate leukocytes. Similarly, autoimmune diseases like lupus and viral infections such as HIV can prompt the immune system...
Bone Marrow Sampling and Transplants01:22

Bone Marrow Sampling and Transplants

Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...
Primary Lymphoid Organs01:16

Primary Lymphoid Organs

Primary lymphoid organs are pivotal in the formation, development, and maturation of lymphocytes, the white blood cells that serve as the backbone of our immune system. This crucial function underscores their fundamental role in maintaining our overall health and immunity. The two primary lymphoid organs of prime importance are the red bone marrow and the thymus.
The red bone marrow is a soft, spongy tissue nestled in the interior of long bones such as the humerus and femur. It is the site...
Lymphoid Cells and Tissues01:18

Lymphoid Cells and Tissues

Lymphoid cells and tissues are integral to the immune system, which is crucial in maintaining our body's defense against harmful pathogens. They form the building blocks of lymphoid organs, which include the spleen, thymus, and lymph nodes.
Lymphoid cells consist of various types of immune system cells. These include B and T lymphocytes, which are responsible for producing antibodies and killing infected cells, respectively. Dendritic cells act as messengers between the innate and adaptive...
Multipotency of Hematopoietic Stem Cells01:19

Multipotency of Hematopoietic Stem Cells

The hematopoietic stem cells or HSCs are multipotent, meaning they can differentiate and give rise to all blood and immune cells. HSCs are maintained in the quiescent stage until an external stimulus initiates their differentiation. The multipotent HSCs exist as two heterogeneous populations, long-term repopulating cells (LTRC) and short-term repopulating cells (STRC). The two HSC populations have different surface markers or receptors and are classified based on quiescence and long-term...